Detalhe da pesquisa
1.
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood
; 118(18): 4817-28, 2011 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21849486